🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open-label, one sequence study to evaluate the steady-state comp...
Status
Completed
Location
Collaborative Neuroscience Network
Start Date
2018-07-09
Trial ID
NCT03527186
Treatments Being Tested
This is a prospective, non-interventional, multicentre study designed to co...
Status
Completed
Location
Investigational site number DE-06
Start Date
2022-10-18
Trial ID
NCT05480046
Treatments Being Tested
This clinical trial is designed to evaluate different dosages of risperidon...
Status
Completed
Location
Multiple Locations
Start Date
2013-04
Trial ID
NCT01788774
Treatments Being Tested
This is the long-term open label extension (OLE) of the study PRISMA-3 (NCT...
Status
Completed
Location
Woodland Research Northwest
Start Date
2017-08-25
Trial ID
NCT03870880
Treatments Being Tested
To characterize the pharmacokinetics (PK) of the injectable intramuscular (...
Status
Completed
Location
St Louis Clinical Trials, LC
Start Date
2014-03
Trial ID
NCT02086786
Treatments Being Tested
The primary objective of the rollover study is to evaluate the long-term sa...
Status
Recruiting
Location
Universitair Ziekenhuis Antwerpen (UZA)
Start Date
2024-11-28
Trial ID
NCT06748001
Treatments Being Tested
This is a multicenter, randomized, double-blind, placebo-controlled study d...
Status
Completed
Location
Woodland Research Northwest
Start Date
2017-06-02
Trial ID
NCT03160521
Treatments Being Tested
This is an Open-Label, One-Sequence Study to Evaluate the Steady- State Com...
Status
Completed
Location
Collaborative NeuroScience Research, LLC
Start Date
2021-03-09
Trial ID
NCT05179525
Treatments Being Tested
The study will comprise two dosing periods in two different cohorts of heal...
Status
Completed
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT01320410
Treatments Being Tested
This is a Phase I, open label, dose escalation study designed to evaluate t...
Status
Completed
Location
Investigational Site Number 42001
Start Date
2017-11-06
Trial ID
NCT03401320
Treatments Being Tested